Skip to content

Perspective Therapeutics CATX Change in Deferred Revenue

Change in Deferred Revenue at other companies

CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-$9.61M+78.5%
Immunome logo
ImmunomeIMNM
$0+100%
Precigen logo
PrecigenPGEN
-$107K+22.5%
Zymeworks logo
ZymeworksZYME
-$340K+83.8%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$0+100%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$16.24M-139%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredRevenue.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's change in deferred revenue?
Perspective Therapeutics (CATX) reported change in deferred revenue of $0 in Q1 2026.
How has Perspective Therapeutics's change in deferred revenue changed year-over-year?
Perspective Therapeutics's change in deferred revenue increased by 100.0% year-over-year, from -$1.4M to $0.
What does change in deferred revenue mean?
Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.